SPI
|
15 628,56
|
-76,45
|
-0,49%
|
Analysen zu SPI-Werten
| 04.07.24 | Richemont Buy | UBS AG | |
| 04.07.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 04.07.24 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 04.07.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 04.07.24 | ABB Buy | Goldman Sachs Group Inc. | |
| 04.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.07.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 03.07.24 | UBS Outperform | RBC Capital Markets | |
| 03.07.24 | Nestlé Sector Perform | RBC Capital Markets | |
| 02.07.24 | DocMorris Buy | Jefferies & Company Inc. | |
| 02.07.24 | Roche Hold | Jefferies & Company Inc. | |
| 02.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.07.24 | Novartis Buy | Deutsche Bank AG | |
| 02.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 02.07.24 | Richemont Buy | UBS AG | |
| 02.07.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 01.07.24 | Roche Hold | Deutsche Bank AG | |
| 01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 01.07.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 27.06.24 | ABB Hold | Jefferies & Company Inc. | |
| 27.06.24 | Richemont Buy | UBS AG | |
| 26.06.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 26.06.24 | Richemont Overweight | Barclays Capital | |
| 26.06.24 | Zurich Insurance Neutral | UBS AG | |
| 26.06.24 | ABB Sell | Deutsche Bank AG | |
| 26.06.24 | ABB Market-Perform | Bernstein Research | |
| 26.06.24 | Richemont Sector Perform | RBC Capital Markets | |
| 25.06.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 25.06.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 24.06.24 | Givaudan Reduce | Baader Bank | |
| 24.06.24 | UBS Hold | Jefferies & Company Inc. | |
| 24.06.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 24.06.24 | ams-OSRAM Equal Weight | Barclays Capital | |
| 24.06.24 | Swiss Re Equal Weight | Barclays Capital | |
| 24.06.24 | Roche Equal Weight | Barclays Capital | |
| 24.06.24 | Novartis Underweight | Barclays Capital | |
| 21.06.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 20.06.24 | Roche Neutral | UBS AG |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.